nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—TOP2A—Etoposide—germ cell cancer	0.195	0.236	CbGbCtD
Sparfloxacin—SLC22A5—Dactinomycin—germ cell cancer	0.182	0.221	CbGbCtD
Sparfloxacin—ABCC2—Vinblastine—germ cell cancer	0.089	0.108	CbGbCtD
Sparfloxacin—ABCC2—Cisplatin—germ cell cancer	0.0816	0.0987	CbGbCtD
Sparfloxacin—ABCC2—Etoposide—germ cell cancer	0.0802	0.0969	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—germ cell cancer	0.053	0.064	CbGbCtD
Sparfloxacin—ABCB1—Dactinomycin—germ cell cancer	0.0463	0.056	CbGbCtD
Sparfloxacin—ABCB1—Vinblastine—germ cell cancer	0.029	0.0351	CbGbCtD
Sparfloxacin—ABCB1—Cisplatin—germ cell cancer	0.0266	0.0322	CbGbCtD
Sparfloxacin—ABCB1—Etoposide—germ cell cancer	0.0261	0.0316	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—germ cell cancer	0.0173	0.0209	CbGbCtD
Sparfloxacin—TOP2A—Vindesine—Vinblastine—germ cell cancer	0.0017	0.291	CbGdCrCtD
Sparfloxacin—TOP2A—Vinorelbine—Vinblastine—germ cell cancer	0.00107	0.184	CbGdCrCtD
Sparfloxacin—TOP2A—Podofilox—Etoposide—germ cell cancer	0.00107	0.184	CbGdCrCtD
Sparfloxacin—TOP2A—Teniposide—Etoposide—germ cell cancer	0.00107	0.184	CbGdCrCtD
Sparfloxacin—TOP2A—Vincristine—Vinblastine—germ cell cancer	0.000914	0.157	CbGdCrCtD
Sparfloxacin—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.000448	0.271	CbGpPWpGaD
Sparfloxacin—Malaise—Bleomycin—germ cell cancer	0.000393	0.00237	CcSEcCtD
Sparfloxacin—Chills—Ifosfamide—germ cell cancer	0.000383	0.00231	CcSEcCtD
Sparfloxacin—Arrhythmia—Ifosfamide—germ cell cancer	0.000382	0.0023	CcSEcCtD
Sparfloxacin—Vaginal infection—Methotrexate—germ cell cancer	0.00038	0.00229	CcSEcCtD
Sparfloxacin—Cough—Bleomycin—germ cell cancer	0.00038	0.00229	CcSEcCtD
Sparfloxacin—Pneumonia—Etoposide—germ cell cancer	0.000378	0.00228	CcSEcCtD
Sparfloxacin—Paraesthesia—Vinblastine—germ cell cancer	0.000378	0.00228	CcSEcCtD
Sparfloxacin—Alopecia—Ifosfamide—germ cell cancer	0.000378	0.00228	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000377	0.00227	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000373	0.00225	CcSEcCtD
Sparfloxacin—Chest pain—Bleomycin—germ cell cancer	0.000371	0.00224	CcSEcCtD
Sparfloxacin—Myalgia—Bleomycin—germ cell cancer	0.000371	0.00224	CcSEcCtD
Sparfloxacin—Stomatitis—Etoposide—germ cell cancer	0.000366	0.00221	CcSEcCtD
Sparfloxacin—Jaundice—Etoposide—germ cell cancer	0.000366	0.00221	CcSEcCtD
Sparfloxacin—Discomfort—Bleomycin—germ cell cancer	0.000366	0.00221	CcSEcCtD
Sparfloxacin—Malaise—Dactinomycin—germ cell cancer	0.000366	0.00221	CcSEcCtD
Sparfloxacin—Decreased appetite—Vinblastine—germ cell cancer	0.000366	0.00221	CcSEcCtD
Sparfloxacin—Ecchymosis—Methotrexate—germ cell cancer	0.000364	0.0022	CcSEcCtD
Sparfloxacin—Mouth ulceration—Methotrexate—germ cell cancer	0.000364	0.0022	CcSEcCtD
Sparfloxacin—Urine output increased—Methotrexate—germ cell cancer	0.000364	0.0022	CcSEcCtD
Sparfloxacin—Constipation—Vinblastine—germ cell cancer	0.00036	0.00217	CcSEcCtD
Sparfloxacin—Pain—Vinblastine—germ cell cancer	0.00036	0.00217	CcSEcCtD
Sparfloxacin—Pulmonary oedema—Methotrexate—germ cell cancer	0.000358	0.00216	CcSEcCtD
Sparfloxacin—Confusional state—Bleomycin—germ cell cancer	0.000358	0.00216	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Bleomycin—germ cell cancer	0.000355	0.00214	CcSEcCtD
Sparfloxacin—Agranulocytosis—Etoposide—germ cell cancer	0.000351	0.00212	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Bleomycin—germ cell cancer	0.000348	0.0021	CcSEcCtD
Sparfloxacin—Feeling abnormal—Vinblastine—germ cell cancer	0.000347	0.00209	CcSEcCtD
Sparfloxacin—Myalgia—Dactinomycin—germ cell cancer	0.000346	0.00209	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000345	0.00208	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000344	0.00208	CcSEcCtD
Sparfloxacin—Tinnitus—Cisplatin—germ cell cancer	0.000343	0.00207	CcSEcCtD
Sparfloxacin—Lymphadenopathy—Methotrexate—germ cell cancer	0.000342	0.00207	CcSEcCtD
Sparfloxacin—Agitation—Ifosfamide—germ cell cancer	0.000342	0.00206	CcSEcCtD
Sparfloxacin—Discomfort—Dactinomycin—germ cell cancer	0.000341	0.00206	CcSEcCtD
Sparfloxacin—Angioedema—Ifosfamide—germ cell cancer	0.00034	0.00205	CcSEcCtD
Sparfloxacin—Anorexia—Bleomycin—germ cell cancer	0.000339	0.00204	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Etoposide—germ cell cancer	0.000336	0.00203	CcSEcCtD
Sparfloxacin—Malaise—Ifosfamide—germ cell cancer	0.000335	0.00202	CcSEcCtD
Sparfloxacin—Vertigo—Ifosfamide—germ cell cancer	0.000334	0.00202	CcSEcCtD
Sparfloxacin—Polyuria—Methotrexate—germ cell cancer	0.000333	0.00201	CcSEcCtD
Sparfloxacin—Abdominal pain—Vinblastine—germ cell cancer	0.000332	0.00201	CcSEcCtD
Sparfloxacin—Arrhythmia—Cisplatin—germ cell cancer	0.000329	0.00199	CcSEcCtD
Sparfloxacin—Palpitations—Ifosfamide—germ cell cancer	0.000329	0.00198	CcSEcCtD
Sparfloxacin—Alopecia—Cisplatin—germ cell cancer	0.000326	0.00196	CcSEcCtD
Sparfloxacin—Hepatic failure—Methotrexate—germ cell cancer	0.000325	0.00196	CcSEcCtD
Sparfloxacin—Cough—Ifosfamide—germ cell cancer	0.000325	0.00196	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000324	0.00196	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000324	0.00195	CcSEcCtD
Sparfloxacin—Convulsion—Ifosfamide—germ cell cancer	0.000322	0.00195	CcSEcCtD
Sparfloxacin—Hypertension—Ifosfamide—germ cell cancer	0.000321	0.00194	CcSEcCtD
Sparfloxacin—Erythema multiforme—Etoposide—germ cell cancer	0.000319	0.00193	CcSEcCtD
Sparfloxacin—Paraesthesia—Bleomycin—germ cell cancer	0.000319	0.00193	CcSEcCtD
Sparfloxacin—Dyspnoea—Bleomycin—germ cell cancer	0.000317	0.00191	CcSEcCtD
Sparfloxacin—Chest pain—Ifosfamide—germ cell cancer	0.000317	0.00191	CcSEcCtD
Sparfloxacin—Arthralgia—Ifosfamide—germ cell cancer	0.000317	0.00191	CcSEcCtD
Sparfloxacin—Myalgia—Ifosfamide—germ cell cancer	0.000317	0.00191	CcSEcCtD
Sparfloxacin—Renal failure acute—Methotrexate—germ cell cancer	0.000317	0.00191	CcSEcCtD
Sparfloxacin—Flatulence—Cisplatin—germ cell cancer	0.000316	0.00191	CcSEcCtD
Sparfloxacin—Anorexia—Dactinomycin—germ cell cancer	0.000316	0.00191	CcSEcCtD
Sparfloxacin—Discomfort—Ifosfamide—germ cell cancer	0.000313	0.00189	CcSEcCtD
Sparfloxacin—Hypersensitivity—Vinblastine—germ cell cancer	0.00031	0.00187	CcSEcCtD
Sparfloxacin—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.00031	0.00187	CcSEcCtD
Sparfloxacin—Decreased appetite—Bleomycin—germ cell cancer	0.000309	0.00186	CcSEcCtD
Sparfloxacin—Confusional state—Ifosfamide—germ cell cancer	0.000306	0.00185	CcSEcCtD
Sparfloxacin—Pain—Bleomycin—germ cell cancer	0.000304	0.00183	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000304	0.00183	CcSEcCtD
Sparfloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.000304	0.184	CbGpPWpGaD
Sparfloxacin—Chills—Etoposide—germ cell cancer	0.000303	0.00183	CcSEcCtD
Sparfloxacin—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000302	0.00182	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000302	0.00182	CcSEcCtD
Sparfloxacin—Asthenia—Vinblastine—germ cell cancer	0.000302	0.00182	CcSEcCtD
Sparfloxacin—Tremor—Cisplatin—germ cell cancer	0.0003	0.00181	CcSEcCtD
Sparfloxacin—Alopecia—Etoposide—germ cell cancer	0.000298	0.0018	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Cisplatin—germ cell cancer	0.000298	0.0018	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000297	0.00179	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000293	0.00177	CcSEcCtD
Sparfloxacin—Feeling abnormal—Bleomycin—germ cell cancer	0.000293	0.00177	CcSEcCtD
Sparfloxacin—Osteoarthritis—Methotrexate—germ cell cancer	0.000292	0.00176	CcSEcCtD
Sparfloxacin—Anorexia—Ifosfamide—germ cell cancer	0.000289	0.00175	CcSEcCtD
Sparfloxacin—Malaise—Cisplatin—germ cell cancer	0.000289	0.00175	CcSEcCtD
Sparfloxacin—Decreased appetite—Dactinomycin—germ cell cancer	0.000288	0.00174	CcSEcCtD
Sparfloxacin—Diarrhoea—Vinblastine—germ cell cancer	0.000288	0.00174	CcSEcCtD
Sparfloxacin—Dysgeusia—Etoposide—germ cell cancer	0.000288	0.00174	CcSEcCtD
Sparfloxacin—Back pain—Etoposide—germ cell cancer	0.000284	0.00172	CcSEcCtD
Sparfloxacin—Pain—Dactinomycin—germ cell cancer	0.000283	0.00171	CcSEcCtD
Sparfloxacin—Urticaria—Bleomycin—germ cell cancer	0.000282	0.0017	CcSEcCtD
Sparfloxacin—Body temperature increased—Bleomycin—germ cell cancer	0.000281	0.00169	CcSEcCtD
Sparfloxacin—Dizziness—Vinblastine—germ cell cancer	0.000278	0.00168	CcSEcCtD
Sparfloxacin—Convulsion—Cisplatin—germ cell cancer	0.000278	0.00168	CcSEcCtD
Sparfloxacin—Mood swings—Methotrexate—germ cell cancer	0.000277	0.00167	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000277	0.00167	CcSEcCtD
Sparfloxacin—Ataxia—Methotrexate—germ cell cancer	0.000275	0.00166	CcSEcCtD
Sparfloxacin—Myalgia—Cisplatin—germ cell cancer	0.000273	0.00165	CcSEcCtD
Sparfloxacin—Feeling abnormal—Dactinomycin—germ cell cancer	0.000273	0.00165	CcSEcCtD
Sparfloxacin—Paraesthesia—Ifosfamide—germ cell cancer	0.000273	0.00165	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Etoposide—germ cell cancer	0.000273	0.00165	CcSEcCtD
Sparfloxacin—Anxiety—Cisplatin—germ cell cancer	0.000272	0.00164	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000271	0.00164	CcSEcCtD
Sparfloxacin—Dyspnoea—Ifosfamide—germ cell cancer	0.000271	0.00163	CcSEcCtD
Sparfloxacin—Somnolence—Ifosfamide—germ cell cancer	0.00027	0.00163	CcSEcCtD
Sparfloxacin—Discomfort—Cisplatin—germ cell cancer	0.00027	0.00163	CcSEcCtD
Sparfloxacin—Vomiting—Vinblastine—germ cell cancer	0.000267	0.00161	CcSEcCtD
Sparfloxacin—Malaise—Etoposide—germ cell cancer	0.000265	0.0016	CcSEcCtD
Sparfloxacin—Vertigo—Etoposide—germ cell cancer	0.000264	0.00159	CcSEcCtD
Sparfloxacin—Decreased appetite—Ifosfamide—germ cell cancer	0.000264	0.00159	CcSEcCtD
Sparfloxacin—Headache—Vinblastine—germ cell cancer	0.000263	0.00159	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000263	0.00159	CcSEcCtD
Sparfloxacin—Body temperature increased—Dactinomycin—germ cell cancer	0.000262	0.00158	CcSEcCtD
Sparfloxacin—Abdominal pain—Dactinomycin—germ cell cancer	0.000262	0.00158	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Cisplatin—germ cell cancer	0.000262	0.00158	CcSEcCtD
Sparfloxacin—Hypersensitivity—Bleomycin—germ cell cancer	0.000262	0.00158	CcSEcCtD
Sparfloxacin—Pain—Ifosfamide—germ cell cancer	0.00026	0.00157	CcSEcCtD
Sparfloxacin—Constipation—Ifosfamide—germ cell cancer	0.00026	0.00157	CcSEcCtD
Sparfloxacin—Cough—Etoposide—germ cell cancer	0.000256	0.00155	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Cisplatin—germ cell cancer	0.000256	0.00155	CcSEcCtD
Sparfloxacin—Tachycardia—Cisplatin—germ cell cancer	0.000255	0.00154	CcSEcCtD
Sparfloxacin—Asthenia—Bleomycin—germ cell cancer	0.000255	0.00154	CcSEcCtD
Sparfloxacin—Convulsion—Etoposide—germ cell cancer	0.000255	0.00154	CcSEcCtD
Sparfloxacin—Hypertension—Etoposide—germ cell cancer	0.000254	0.00153	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Cisplatin—germ cell cancer	0.000253	0.00153	CcSEcCtD
Sparfloxacin—Asthma—Methotrexate—germ cell cancer	0.000253	0.00152	CcSEcCtD
Sparfloxacin—Pruritus—Bleomycin—germ cell cancer	0.000251	0.00152	CcSEcCtD
Sparfloxacin—Feeling abnormal—Ifosfamide—germ cell cancer	0.00025	0.00151	CcSEcCtD
Sparfloxacin—Chest pain—Etoposide—germ cell cancer	0.00025	0.00151	CcSEcCtD
Sparfloxacin—Nausea—Vinblastine—germ cell cancer	0.00025	0.00151	CcSEcCtD
Sparfloxacin—Anorexia—Cisplatin—germ cell cancer	0.000249	0.00151	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000248	0.0015	CcSEcCtD
Sparfloxacin—Pancreatitis—Methotrexate—germ cell cancer	0.000248	0.00149	CcSEcCtD
Sparfloxacin—Discomfort—Etoposide—germ cell cancer	0.000247	0.00149	CcSEcCtD
Sparfloxacin—Hypersensitivity—Dactinomycin—germ cell cancer	0.000244	0.00147	CcSEcCtD
Sparfloxacin—Confusional state—Etoposide—germ cell cancer	0.000242	0.00146	CcSEcCtD
Sparfloxacin—Urticaria—Ifosfamide—germ cell cancer	0.000241	0.00146	CcSEcCtD
Sparfloxacin—Body temperature increased—Ifosfamide—germ cell cancer	0.00024	0.00145	CcSEcCtD
Sparfloxacin—Abdominal pain—Ifosfamide—germ cell cancer	0.00024	0.00145	CcSEcCtD
Sparfloxacin—Pancytopenia—Methotrexate—germ cell cancer	0.00024	0.00145	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Etoposide—germ cell cancer	0.00024	0.00145	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000238	0.00144	CcSEcCtD
Sparfloxacin—Asthenia—Dactinomycin—germ cell cancer	0.000238	0.00143	CcSEcCtD
Sparfloxacin—Dysuria—Methotrexate—germ cell cancer	0.000236	0.00143	CcSEcCtD
Sparfloxacin—Paraesthesia—Cisplatin—germ cell cancer	0.000235	0.00142	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Etoposide—germ cell cancer	0.000235	0.00142	CcSEcCtD
Sparfloxacin—Tachycardia—Etoposide—germ cell cancer	0.000234	0.00141	CcSEcCtD
Sparfloxacin—Dyspnoea—Cisplatin—germ cell cancer	0.000233	0.00141	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Etoposide—germ cell cancer	0.000232	0.0014	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000231	0.00139	CcSEcCtD
Sparfloxacin—Anorexia—Etoposide—germ cell cancer	0.000229	0.00138	CcSEcCtD
Sparfloxacin—Decreased appetite—Cisplatin—germ cell cancer	0.000228	0.00137	CcSEcCtD
Sparfloxacin—Diarrhoea—Dactinomycin—germ cell cancer	0.000227	0.00137	CcSEcCtD
Sparfloxacin—Pneumonia—Methotrexate—germ cell cancer	0.000226	0.00137	CcSEcCtD
Sparfloxacin—Vomiting—Bleomycin—germ cell cancer	0.000226	0.00136	CcSEcCtD
Sparfloxacin—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000224	0.136	CbGpPWpGaD
Sparfloxacin—Rash—Bleomycin—germ cell cancer	0.000224	0.00135	CcSEcCtD
Sparfloxacin—Pain—Cisplatin—germ cell cancer	0.000224	0.00135	CcSEcCtD
Sparfloxacin—Dermatitis—Bleomycin—germ cell cancer	0.000224	0.00135	CcSEcCtD
Sparfloxacin—Hypersensitivity—Ifosfamide—germ cell cancer	0.000224	0.00135	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000223	0.00135	CcSEcCtD
Sparfloxacin—Stomatitis—Methotrexate—germ cell cancer	0.00022	0.00132	CcSEcCtD
Sparfloxacin—Conjunctivitis—Methotrexate—germ cell cancer	0.000219	0.00132	CcSEcCtD
Sparfloxacin—Asthenia—Ifosfamide—germ cell cancer	0.000218	0.00131	CcSEcCtD
Sparfloxacin—Sweating—Methotrexate—germ cell cancer	0.000216	0.0013	CcSEcCtD
Sparfloxacin—Feeling abnormal—Cisplatin—germ cell cancer	0.000216	0.0013	CcSEcCtD
Sparfloxacin—Paraesthesia—Etoposide—germ cell cancer	0.000215	0.0013	CcSEcCtD
Sparfloxacin—Pruritus—Ifosfamide—germ cell cancer	0.000215	0.0013	CcSEcCtD
Sparfloxacin—Haematuria—Methotrexate—germ cell cancer	0.000215	0.0013	CcSEcCtD
Sparfloxacin—Dyspnoea—Etoposide—germ cell cancer	0.000214	0.00129	CcSEcCtD
Sparfloxacin—Somnolence—Etoposide—germ cell cancer	0.000213	0.00129	CcSEcCtD
Sparfloxacin—Epistaxis—Methotrexate—germ cell cancer	0.000212	0.00128	CcSEcCtD
Sparfloxacin—Nausea—Bleomycin—germ cell cancer	0.000211	0.00127	CcSEcCtD
Sparfloxacin—Vomiting—Dactinomycin—germ cell cancer	0.000211	0.00127	CcSEcCtD
Sparfloxacin—Agranulocytosis—Methotrexate—germ cell cancer	0.00021	0.00127	CcSEcCtD
Sparfloxacin—Rash—Dactinomycin—germ cell cancer	0.000209	0.00126	CcSEcCtD
Sparfloxacin—Decreased appetite—Etoposide—germ cell cancer	0.000208	0.00126	CcSEcCtD
Sparfloxacin—Diarrhoea—Ifosfamide—germ cell cancer	0.000208	0.00125	CcSEcCtD
Sparfloxacin—Body temperature increased—Cisplatin—germ cell cancer	0.000207	0.00125	CcSEcCtD
Sparfloxacin—Pain—Etoposide—germ cell cancer	0.000205	0.00124	CcSEcCtD
Sparfloxacin—Constipation—Etoposide—germ cell cancer	0.000205	0.00124	CcSEcCtD
Sparfloxacin—Haemoglobin—Methotrexate—germ cell cancer	0.000203	0.00123	CcSEcCtD
Sparfloxacin—Hepatitis—Methotrexate—germ cell cancer	0.000202	0.00122	CcSEcCtD
Sparfloxacin—Haemorrhage—Methotrexate—germ cell cancer	0.000202	0.00122	CcSEcCtD
Sparfloxacin—Dizziness—Ifosfamide—germ cell cancer	0.000201	0.00121	CcSEcCtD
Sparfloxacin—Pharyngitis—Methotrexate—germ cell cancer	0.000201	0.00121	CcSEcCtD
Sparfloxacin—Feeling abnormal—Etoposide—germ cell cancer	0.000198	0.00119	CcSEcCtD
Sparfloxacin—Nausea—Dactinomycin—germ cell cancer	0.000197	0.00119	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Etoposide—germ cell cancer	0.000196	0.00118	CcSEcCtD
Sparfloxacin—Vomiting—Ifosfamide—germ cell cancer	0.000193	0.00117	CcSEcCtD
Sparfloxacin—Hypersensitivity—Cisplatin—germ cell cancer	0.000193	0.00116	CcSEcCtD
Sparfloxacin—Rash—Ifosfamide—germ cell cancer	0.000191	0.00116	CcSEcCtD
Sparfloxacin—Dermatitis—Ifosfamide—germ cell cancer	0.000191	0.00115	CcSEcCtD
Sparfloxacin—Erythema multiforme—Methotrexate—germ cell cancer	0.000191	0.00115	CcSEcCtD
Sparfloxacin—Urticaria—Etoposide—germ cell cancer	0.00019	0.00115	CcSEcCtD
Sparfloxacin—Abdominal pain—Etoposide—germ cell cancer	0.00019	0.00114	CcSEcCtD
Sparfloxacin—Body temperature increased—Etoposide—germ cell cancer	0.00019	0.00114	CcSEcCtD
Sparfloxacin—Tinnitus—Methotrexate—germ cell cancer	0.000188	0.00114	CcSEcCtD
Sparfloxacin—Asthenia—Cisplatin—germ cell cancer	0.000188	0.00113	CcSEcCtD
Sparfloxacin—Chills—Methotrexate—germ cell cancer	0.000181	0.00109	CcSEcCtD
Sparfloxacin—Nausea—Ifosfamide—germ cell cancer	0.00018	0.00109	CcSEcCtD
Sparfloxacin—Diarrhoea—Cisplatin—germ cell cancer	0.000179	0.00108	CcSEcCtD
Sparfloxacin—Alopecia—Methotrexate—germ cell cancer	0.000179	0.00108	CcSEcCtD
Sparfloxacin—Hypersensitivity—Etoposide—germ cell cancer	0.000177	0.00107	CcSEcCtD
Sparfloxacin—Dysgeusia—Methotrexate—germ cell cancer	0.000172	0.00104	CcSEcCtD
Sparfloxacin—Asthenia—Etoposide—germ cell cancer	0.000172	0.00104	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—germ cell cancer	0.00017	0.00103	CcSEcCtD
Sparfloxacin—Pruritus—Etoposide—germ cell cancer	0.00017	0.00102	CcSEcCtD
Sparfloxacin—Vomiting—Cisplatin—germ cell cancer	0.000166	0.001	CcSEcCtD
Sparfloxacin—Rash—Cisplatin—germ cell cancer	0.000165	0.000996	CcSEcCtD
Sparfloxacin—Dermatitis—Cisplatin—germ cell cancer	0.000165	0.000995	CcSEcCtD
Sparfloxacin—Diarrhoea—Etoposide—germ cell cancer	0.000164	0.00099	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—germ cell cancer	0.000163	0.000985	CcSEcCtD
Sparfloxacin—Malaise—Methotrexate—germ cell cancer	0.000159	0.000958	CcSEcCtD
Sparfloxacin—Dizziness—Etoposide—germ cell cancer	0.000159	0.000957	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—germ cell cancer	0.000158	0.000954	CcSEcCtD
Sparfloxacin—Nausea—Cisplatin—germ cell cancer	0.000155	0.000938	CcSEcCtD
Sparfloxacin—Cough—Methotrexate—germ cell cancer	0.000154	0.000927	CcSEcCtD
Sparfloxacin—Convulsion—Methotrexate—germ cell cancer	0.000152	0.00092	CcSEcCtD
Sparfloxacin—Vomiting—Etoposide—germ cell cancer	0.000152	0.00092	CcSEcCtD
Sparfloxacin—Rash—Etoposide—germ cell cancer	0.000151	0.000912	CcSEcCtD
Sparfloxacin—Dermatitis—Etoposide—germ cell cancer	0.000151	0.000912	CcSEcCtD
Sparfloxacin—Headache—Etoposide—germ cell cancer	0.00015	0.000907	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—germ cell cancer	0.00015	0.000904	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—germ cell cancer	0.00015	0.000904	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—germ cell cancer	0.00015	0.000904	CcSEcCtD
Sparfloxacin—Discomfort—Methotrexate—germ cell cancer	0.000148	0.000893	CcSEcCtD
Sparfloxacin—Confusional state—Methotrexate—germ cell cancer	0.000145	0.000874	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—germ cell cancer	0.000144	0.000867	CcSEcCtD
Sparfloxacin—Nausea—Etoposide—germ cell cancer	0.000142	0.00086	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—germ cell cancer	0.000141	0.000849	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Methotrexate—germ cell cancer	0.000139	0.000838	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—germ cell cancer	0.000137	0.000826	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000131	0.00079	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—germ cell cancer	0.00013	0.000784	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—germ cell cancer	0.000129	0.000778	CcSEcCtD
Sparfloxacin—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000129	0.0779	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Methotrexate—germ cell cancer	0.000128	0.000773	CcSEcCtD
Sparfloxacin—Somnolence—Methotrexate—germ cell cancer	0.000128	0.000771	CcSEcCtD
Sparfloxacin—Dyspepsia—Methotrexate—germ cell cancer	0.000126	0.000763	CcSEcCtD
Sparfloxacin—Decreased appetite—Methotrexate—germ cell cancer	0.000125	0.000754	CcSEcCtD
Sparfloxacin—Pain—Methotrexate—germ cell cancer	0.000123	0.000741	CcSEcCtD
Sparfloxacin—Feeling abnormal—Methotrexate—germ cell cancer	0.000118	0.000714	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000117	0.000709	CcSEcCtD
Sparfloxacin—Urticaria—Methotrexate—germ cell cancer	0.000114	0.000689	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—germ cell cancer	0.000114	0.000685	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—germ cell cancer	0.000114	0.000685	CcSEcCtD
Sparfloxacin—Hypersensitivity—Methotrexate—germ cell cancer	0.000106	0.000639	CcSEcCtD
Sparfloxacin—Asthenia—Methotrexate—germ cell cancer	0.000103	0.000622	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—germ cell cancer	0.000102	0.000613	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—germ cell cancer	9.83e-05	0.000593	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—germ cell cancer	9.5e-05	0.000573	CcSEcCtD
Sparfloxacin—Vomiting—Methotrexate—germ cell cancer	9.13e-05	0.000551	CcSEcCtD
Sparfloxacin—Rash—Methotrexate—germ cell cancer	9.06e-05	0.000547	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—germ cell cancer	9.05e-05	0.000546	CcSEcCtD
Sparfloxacin—Headache—Methotrexate—germ cell cancer	9e-05	0.000543	CcSEcCtD
Sparfloxacin—Nausea—Methotrexate—germ cell cancer	8.53e-05	0.000515	CcSEcCtD
Sparfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	6.17e-05	0.0373	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	6.08e-05	0.0368	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	3.61e-05	0.0218	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	3.25e-05	0.0197	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—MYC—germ cell cancer	2.84e-05	0.0172	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	2.81e-05	0.017	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	2.76e-05	0.0167	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—TP53—germ cell cancer	2.34e-05	0.0141	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.18e-05	0.0132	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—AVP—germ cell cancer	1.66e-05	0.01	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.59e-05	0.00964	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.43e-05	0.00862	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.4e-05	0.00849	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	1.29e-05	0.00783	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	1.25e-05	0.00754	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	1.18e-05	0.00714	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.04e-05	0.0063	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.03e-05	0.00621	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	1.02e-05	0.00619	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	9.31e-06	0.00563	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—germ cell cancer	8.77e-06	0.0053	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—H2AFZ—germ cell cancer	8.32e-06	0.00503	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.49e-06	0.00453	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	6.64e-06	0.00402	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	6.57e-06	0.00398	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	6.49e-06	0.00393	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.45e-06	0.0033	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—germ cell cancer	5.24e-06	0.00317	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.9e-06	0.00296	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.83e-06	0.00292	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	4.81e-06	0.00291	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—germ cell cancer	3.21e-06	0.00194	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—germ cell cancer	2.87e-06	0.00174	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—germ cell cancer	2.36e-06	0.00143	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.3e-06	0.00139	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.26e-06	0.00137	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.26e-06	0.00137	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.19e-06	0.00132	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CRABP1—germ cell cancer	1.84e-06	0.00111	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.8e-06	0.00109	CbGpPWpGaD
